FLX475   Click here for help

GtoPdb Ligand ID: 12153

Synonyms: example 43 [WO2018022992A1] | FLX-475
Immunopharmacology Ligand
Compound class: Synthetic organic
Comment: FLX475 is an orally bioavailable CCR4 antagonist that was developed by RAPT Therapeutics, and is one of the structures claimed in patent WO2018022992A1 [1]. Antagonising CCR4 is proposed to activate the immune response against Epstein-Barr Virus (EBV)-positive tumours [2]. FLX475's chemical structure was revealed during the first disclosures session at the 2022 ACS meeting in Chicago.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 6
Hydrogen bond donors 1
Rotatable bonds 7
Topological polar surface area 70.31
Molecular weight 542.16
XLogP 5.59
No. Lipinski's rules broken 1
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES OCCN1CCC[C@@H](C1)C1CN(C1)c1cnc2c(n1)n(nc2C(F)(F)F)[C@@H](c1ccc(cc1Cl)Cl)C
Isomeric SMILES C[C@H](c1c(cc(cc1)Cl)Cl)n1c2nc(cnc2c(n1)C(F)(F)F)N1CC(C1)[C@H]1CCCN(C1)CCO
InChI InChI=1S/C24H27Cl2F3N6O/c1-14(18-5-4-17(25)9-19(18)26)35-23-21(22(32-35)24(27,28)29)30-10-20(31-23)34-12-16(13-34)15-3-2-6-33(11-15)7-8-36/h4-5,9-10,14-16,36H,2-3,6-8,11-13H2,1H3/t14-,15+/m1/s1
InChI Key AKSVALRPYDVQBS-CABCVRRESA-N
Download 2D Structure Click here for help
Canonical SMILES Download
Isomeric SMILES Download
InChI standard identifier Download
InChI standard key Download

Molecular structure representations generated using Open Babel